Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven P Gygi

Showing results (711-720 of 725) with videos related to

Pageof 73
Sort By:
Cell Metabolism|February 18, 2025
Ergothioneine controls mitochondrial function and exercise performance via direct activation of MPSTHans-Georg Sprenger, Melanie J Mittenbühler, Yizhi Sun, et al.
Nature|October 2, 2025
Publisher Correction: Multimodal cell maps as a foundation for structural and functional genomicsLeah V Schaffer, Mengzhou Hu, Gege Qian, et al.
Cell Reports. Medicine|January 14, 2022
Multiomic analysis identifies CPT1A as a potential therapeutic target in platinum-refractory, high-grade serous ovarian cancerDongqing Huang, Shrabanti Chowdhury, Hong Wang, et al.
Nature|April 9, 2025
Multimodal cell maps as a foundation for structural and functional genomicsLeah V Schaffer, Mengzhou Hu, Gege Qian, et al.
Nature|May 20, 2026
Mitochondrial L-2-hydroxyglutarate is a physiological signalling metaboliteRam P Chakrabarty, Jonathan G Van Vranken, Yuki Aoi, et al.
Cancer Discovery|April 7, 2019
Tissue-Specific Oncogenic Activity of KRAS<sup>A146T</sup>Emily J Poulin, Asim K Bera, Jia Lu, et al.
Biorxiv : the Preprint Server for Biology|August 6, 2025
On-target toxicity limits the efficacy of CDK11 inhibition against cancers with 1p36 deletionsLinda Julian, Lisa Crozier, Devon Lukow, et al.
Nature Cardiovascular Research|September 24, 2025
Cardiac adaptation to endurance exercise training requires suppression of GDF15 via PGC-1αSumeet A Khetarpal, Haobo Li, Tevis Vitale, et al.
Nature Biomedical Engineering|May 4, 2021
A human-airway-on-a-chip for the rapid identification of candidate antiviral therapeutics and prophylacticsLonglong Si, Haiqing Bai, Melissa Rodas, et al.
Nature Cell Biology|October 27, 2014
Cyclin C is a haploinsufficient tumour suppressorNa Li, Anne Fassl, Joel Chick, et al.
Pageof 73

Showing results (711-720 of 725) with videos related to

Sort By:
Pageof 73
Cell Metabolism|February 18, 2025
Ergothioneine controls mitochondrial function and exercise performance via direct activation of MPSTHans-Georg Sprenger, Melanie J Mittenbühler, Yizhi Sun, et al.
Nature|October 2, 2025
Publisher Correction: Multimodal cell maps as a foundation for structural and functional genomicsLeah V Schaffer, Mengzhou Hu, Gege Qian, et al.
Cell Reports. Medicine|January 14, 2022
Multiomic analysis identifies CPT1A as a potential therapeutic target in platinum-refractory, high-grade serous ovarian cancerDongqing Huang, Shrabanti Chowdhury, Hong Wang, et al.
Nature|April 9, 2025
Multimodal cell maps as a foundation for structural and functional genomicsLeah V Schaffer, Mengzhou Hu, Gege Qian, et al.
Nature|May 20, 2026
Mitochondrial L-2-hydroxyglutarate is a physiological signalling metaboliteRam P Chakrabarty, Jonathan G Van Vranken, Yuki Aoi, et al.
Cancer Discovery|April 7, 2019
Tissue-Specific Oncogenic Activity of KRAS<sup>A146T</sup>Emily J Poulin, Asim K Bera, Jia Lu, et al.
Biorxiv : the Preprint Server for Biology|August 6, 2025
On-target toxicity limits the efficacy of CDK11 inhibition against cancers with 1p36 deletionsLinda Julian, Lisa Crozier, Devon Lukow, et al.
Nature Cardiovascular Research|September 24, 2025
Cardiac adaptation to endurance exercise training requires suppression of GDF15 via PGC-1αSumeet A Khetarpal, Haobo Li, Tevis Vitale, et al.
Nature Biomedical Engineering|May 4, 2021
A human-airway-on-a-chip for the rapid identification of candidate antiviral therapeutics and prophylacticsLonglong Si, Haiqing Bai, Melissa Rodas, et al.
Nature Cell Biology|October 27, 2014
Cyclin C is a haploinsufficient tumour suppressorNa Li, Anne Fassl, Joel Chick, et al.
Pageof 73